SCHEMBL20711481

SCHEMBL20711481

COc1ccccc1NNC(=O)C(=O)NN

nearest known ligand 0.62

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GAA P10253 7/20 0.62
KDM4E B2RXH2 3/20 0.50
TDP1 Q9NUW8 2/20 0.50
CTSD P07339 1/20 0.50
ALDH1A1 P00352 7/20 0.49
MAPT P10636 5/20 0.48
LMNA P02545 1/20 0.48
HTT P42858 1/20 0.47
POLB P06746 1/20 0.46
CASP6 P55212 1/20 0.46
CLK1 P49759 1/20 0.45
KMT2A Q03164 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
HSD17B10 Q99714 1/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20984472 0.92 GAA (0.71) GAAKDM4ETDP1ALDH1A1MAPT
SCHEMBL10589209 0.85 GAA (0.64) GAAKDM4ETDP1ALDH1A1MAPT
SCHEMBL9504533 0.83 ALDH1A1 (0.61) GAAKDM4ETDP1CTSDALDH1A1
SCHEMBL29676195 0.81 ALDH1A1 (0.61) GAAALDH1A1MAPTLMNAHTT
SCHEMBL11326923 0.81 ALDH1A1 (0.61) GAAALDH1A1MAPTLMNAHTT
SCHEMBL14518046 0.81 GAA (0.68) GAAKDM4ETDP1ALDH1A1MAPT
SCHEMBL2233791 0.80 GAA (0.60) GAAALDH1A1MAPTLMNAHTT
SCHEMBL29163015 0.80 GAA (0.65) GAAALDH1A1MAPTLMNACLK1
SCHEMBL15568571 0.80 GAA (0.60) GAAKDM4ETDP1ALDH1A1MAPT
SCHEMBL9036508 0.78 ALDH1A1 (0.71) GAAKDM4EALDH1A1MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3661912-B9 COMPOUNDS FOR TREATING INFECTIONS HORITZONTS TECNOLOGICS HUNGARY KORLATOLT FELELOSSEGU TARSASAG (HU) 2024-02-28 EP disclosed
EP-3661912-B1 COMPOUNDS FOR TREATING INFECTIONS HORITZONTS TECNOLOGICS HUNGARY KORLATOLT FELELOSSEGU TARSASAG (HU) 2023-11-22 EP disclosed
US-20230348365-A1 COMPOUNDS FOR TREATING INFECTIONS ARTS & CIÈNCIES EUROPA (AD) 2023-11-02 US disclosed
US-11584710-B2 Compounds for treating infections HORITZONTS TECNOLOGICS HUNGARY KORLÁTOLT FELELOSSÉGU TÁRSASÁG (HU) 2023-02-21 US disclosed
US-20210155578-A1 COMPOUNDS FOR TREATING INFECTIONS ARTS & CIÈNCIES EUROPA (AD) 2021-05-27 US disclosed
WO-2019025426-A1 COMPOUNDS FOR TREATING INFECTIONS HORITZONTS TECNOLOGICS HUNGARY KORLÁTOLT FELELOSSÉGU TÁRSASÁG (HU) 2019-02-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210155578-A1 COMPOUNDS FOR TREATING INFECTIONS DPM1, TREH, MPO GAA 244/4885KDM4E 2557/4885TDP1 4137/4885
US-20230348365-A1 COMPOUNDS FOR TREATING INFECTIONS DPM1, TREH, MPO GAA 244/4885KDM4E 2557/4885TDP1 4137/4885
US-11584710-B2 Compounds for treating infections DPM1, TREH, MPO GAA 244/4885KDM4E 2557/4885TDP1 4137/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.